Joel Greenblatt’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$551K Buy
3,864
+1,181
+44% +$179K ﹤0.01% 1567
2026
Q2
$420K Hold
2,683
– – ﹤0.01% 1560
2026
Q1
$410K Sell
2,683
-72
-3% -$11K ﹤0.01% 1532
2025
Q4
$380K Buy
2,755
+799
+41% +$105K ﹤0.01% 1509
2025
Q3
$251K Buy
1,956
+191
+11% +$23.3K ﹤0.01% 1555
2025
Q2
$214K Buy
+1,765
New +$199K ﹤0.01% 1555

Other funds holding NVS

Joel Greenblatt's NVS Position: Q3 2026 in Review

Joel Greenblatt increased its Novartis (NVS) stake by 44% in Q3 2026, buying an estimated $179K and bringing the position to 3,864 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

Joel Greenblatt first reported a position in NVS in Q2 2025 and has held it in 6 quarters since. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Joel Greenblatt held 3,864 shares of Novartis worth $551K as of Q3 2026.
  • Joel Greenblatt bought 1,181 Novartis shares in Q3 2026, an estimated $179K.
  • Novartis made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1567 holding.
  • Joel Greenblatt first reported a position in Novartis in Q2 2025 and has held it in 6 quarters since.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.